COVID-19 update included
The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic

The Europe Infusion Pumps & Accessories Market would witness market growth of 5.1% CAGR during the forecast period (2017 – 2023).
Infusion pumps and accessories are a set of drugs delivering devices which are used to administer medications in a controlled, precise and automated manner. These devices are for therapeutic purposes, and come handy in critical care, pain management and other applications, to administer medications on a continuous basis to ensure patients comfort and also offer pain-free therapy.

Swift rise in patients with chronic diseases such as diabetes and gastrointestinal disorders is one of major growth factors that is fueling the market growth. Furthermore, surge in demand of portable infusion pump to minimize hospital expenditure and increasing user’s inclination toward home care medical equipment further propel the market growth.

Based on product the market is segmented into Devices & Pumps and Accessories & Disposables. Devices & Pumps further categorised into Syringe Infusion Pumps, Insulin Infusion Pumps, Volumetric Infusion Pumps, Ambulatory Infusion Pumps, Patient Controlled Analgesia Pumps, Implantable Infusion Pumps, and Enteral Infusion Pumps. Accessories & Disposables segment includes Infusion Catheters, Valves, IV sets, Cannulas, Tubing, Needles, and Other. Disposables Based on end user, the market is segmented into Hospitals, Home Care, Ambulatory Surgical Centers (ASCs), and Other End User. Based on application, the market is segmented into Gastroenterology, Diabetes, Analgesia & Pain Management Chemotherapy, Pediatrics & Neonatology, and Other Application. Based on countries, the Infusion Pumps & Accessories market segments the market into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the Europe Infusion Pumps & Accessories Market. Key companies profiled in the report include Mindray Medical International Limited, B. Braun Melsungen AG, Becton, Dickinson and Company, Baxter International Inc, Chemyx Inc., Hoffmann-la Roche Ltd, Pfizer Inc, Medtronic, Inc., Terumo Corporation, and Smiths Medical.